New hope for kids with tough cancers: trial tests aggressive drug combo
NCT ID NCT07444918
Summary
This study is testing a combination of four cancer drugs to see if they can shrink tumors in children and teenagers whose solid cancers have come back or haven't responded to standard treatments. It will involve about 33 young patients with cancers like neuroblastoma or bone cancers. The main goal is to see how well the tumors respond to the treatment and to carefully monitor side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED OR REFRACTORY PEDIATRIC MALIGNANT SOLID TUMORS (INCLUDING NEUROBLASTOMA, RHABDOMYOSARCOMA, EWING SARCOMA, OSTEOSARCOMA) are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.